HomeNXTCL • STO
add
NextCell Pharma AB
Previous close
kr 2.60
Day range
kr 2.40 - kr 2.62
Year range
kr 1.16 - kr 4.03
Market cap
178.34M SEK
Avg Volume
519.80K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Aug 2024info | Y/Y change |
|---|---|---|
Revenue | 1.70M | -57.79% |
Operating expense | 8.20M | -20.10% |
Net income | -13.25M | -54.62% |
Net profit margin | -781.01 | -266.29% |
Earnings per share | — | — |
EBITDA | -12.96M | -46.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Aug 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 46.79M | -6.47% |
Total assets | 81.29M | -8.49% |
Total liabilities | 13.69M | 4.49% |
Total equity | 67.60M | — |
Shares outstanding | 73.09M | — |
Price to book | 2.83 | — |
Return on assets | -47.78% | — |
Return on capital | -59.36% | — |
Cash Flow
Net change in cash
| (SEK) | Aug 2024info | Y/Y change |
|---|---|---|
Net income | -13.25M | -54.62% |
Cash from operations | -7.95M | 39.57% |
Cash from investing | -587.00 | 99.80% |
Cash from financing | 33.95M | 13,687.12% |
Net change in cash | 25.99M | 296.85% |
Free cash flow | -3.26M | 68.93% |
About
Founded
2014
Website
Employees
24
